SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGemfields Grou. Regulatory News (GEM)

Share Price Information for Gemfields Grou. (GEM)

Share Price is delayed by 15 minutes
Get Live Data
4.10    0.00 (0.00%)
Bid:
3.70
Ask:
4.50
Spread: 0.80 (21.622%)
Market Cap: £70.69m
GEM Live PriceLast checked at - London Stock Exchange

Intraday Gemfields Grou. Share Chart

EGM Statement

5 Jun 2008 15:23

RNS Number : 0937W
Gemfields Resources PLC
05 June 2008
 

Gemfields Resources PLC

Extraordinary General Meeting

5 June 2008

Shareholders approve Rox acquisition

The Board of Gemfields Resources PLC ('Gemfields' or the 'Company') (AIM: GEM) is pleased to announce that all resolutions put to the Extraordinary General Meeting (EGM) held today at 10a.m. CET (9a.m. BST) were duly passed, including:

1. The approval of the Acquisition of the entire issued share capital of Greentop and Krinera in consideration for the issue to Rox of 137,910,340 new Ordinary Shares in Gemfields.

2. To increase the authorised share capital of the Company from £2,000,000 to £6,000,000 and authorise the Directors to allot sufficient Ordinary Shares to effect the Acquisition and the Placing and also to allot further shares up to an aggregate nominal amount of £1,000,000.

3. The approval of an extension to the term during which share options granted to Peter Kitchen, Sanjay Khandelwal and Valentine Chitalu (directors of the Company who resigned immediately prior to publication of the admission document) will be exercisable up to any time prior to the third anniversary of Admission.

4. To empower the Directors, pursuant to section 95(1) of the Act, to allot equity securities on a non pre-emptive basis in respect of, inter alia, the Acquisition and the Placing and up to an additional aggregate nominal amount of £650,000.

A resolution to change the name of the Company from Gemfields Resources plc to Gemfields plc was not put to the EGM.

Accordingly, readmission of the existing Ordinary Shares of the Company together with the admission of the new Ordinary Shares to be issued pursuant to the Placing and Acquisition is expected to take place at 8.00am on 6 June 2008, at which point the proposed Acquisition will complete. 

With effect from Admission, Sean Gilbertson will be appointed to the board as the interim CEO and Finn Behnken will be appointed as a non-executive director.

Graham Mascall, Gemfields' Chairman, said: 'This is a milestone for Gemfields and its shareholders. As a result of the Placing and the Acquisition we are now in a strong position to establish the Company as a leading source of high quality Zambian emeralds through consolidation and vertical integration on an international scale. The acquisition provides the Company with substantial and important building blocks for the future. Gemfields now has an immediate cash generating business through its interest in the Kagem mine, and the opportunity to optimise the value of the Company's best gemstones through the use of the Fabergé brand name.

As announced previously, Gemfields' board changes will take effect from Admission and we are pleased to welcome to the board Sean Gilbertson as interim CEO and Finn Behnken as Non Executive Director.

I have known Sean for many years and believe he has excellent experience that will prove invaluable in driving the Company forward."

For more information:

Richard James, CFO richard.james@gemfields.co.uk

Gemfields Resources Plc Tel: +44 (0)20 7016 9416

Mike Jones/Tarica Mpinga +44 (0)20 7050 6500

Canaccord Adams Limited

Neil Passmore/Sam Critchlow  +44 (0) 20 7588 2828

JPMorgan Cazenove

Charlie Geller/Ed Portman  +44 (0)20 7429 6666/ +44 (0) 7528 233 383

Conduit PR

Canaccord Adams Limited (''Canaccord''), which is regulated and authorised in the United Kingdom by the Financial Services Authority, is acting as nominated adviser, joint broker, joint bookrunner and joint co-lead manager to the Company in relation to the Admission and the Placing. Canaccord is not acting for any other persons and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Canaccord or for providing advice in relation to the contents of this document, the application for Admission or the Placing. Canaccord has not authorised any part of this document. No liability is accepted by Canaccord for the accuracy of any information or opinions contained in or for the omission of any information from this document for which the Directors, the Proposed Directors and the Company are responsible.

JPMorgan Cazenove Limited (''JPMorgan Cazenove''), which is regulated and authorised in the United Kingdom by the Financial Services Authority, is acting as joint broker, joint bookrunner and joint co-lead manager to the Company in relation to the Admission and the Placing. JPMorgan Cazenove is not acting for any other persons and will not be responsible to anyone other than the Company for providing the protections afforded to customers of JPMorgan Cazenove or for providing advice in relation to the contents of this document, the application for Admission or the Placing. JPMorgan Cazenove has not authorised any part of this document. No liability is accepted by JPMorgan Cazenove for the accuracy of any information or opinions contained in or for the omission of any information from this document for which the Directors, the Proposed Directors and the Company are responsible.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMFKPKDQBKDFAK
Date   Source Headline
24th Oct 20227:00 amRNSMRM Operational Update
20th Oct 202210:40 amRNSUpdate regarding Cabo Delgado insurgency
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20228:00 amRNSDividend Finalisation
7th Oct 20229:15 amRNSDirector/PDMR Shareholding
6th Oct 20223:11 pmRNSStandard form for notification of major holdings
6th Oct 20223:10 pmRNSNotification of major holdings
5th Oct 20227:00 amRNSPDMR Dealing, Issue of Equity and TVR Update
29th Sep 20227:00 amRNSInterim Results for 6 Months Ending 30 June 2022
27th Sep 20227:00 amRNSMRM Commercial-Quality Auction Results
26th Sep 20227:00 amRNSTrading Statement
20th Sep 20227:00 amRNSEmerald Auction Results
15th Sep 202212:00 pmRNSIssue of Equity and Total Voting Rights update
1st Sep 20227:00 amRNSRemuneration Policy and Long Term Incentive Plan
31st Aug 20227:00 amRNSIssue of Equity and Total Voting Rights update
24th Aug 20227:00 amRNSIssue of Equity and Total Voting Rights update
27th Jul 20227:00 amRNSMarket Update: Operating Results to 30 June 2022
20th Jul 20227:00 amRNSUpdate regarding Cabo Delgado insurgency
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 202212:00 pmRNSCancellation of Issue of Equity and TVR update
30th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights update
29th Jun 20221:00 pmRNSResult of AGM
23rd Jun 20227:00 amRNSIssue of Equity and Total Voting Rights Update
20th Jun 20227:00 amRNSRecord Ruby Auction Results
15th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights update
13th Jun 202211:00 amRNSUpdate regarding Cabo Delgado insurgency
9th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights update
1st Jun 202212:00 pmRNSDisclosure of beneficial interests in securities
1st Jun 202212:00 pmRNSHolding(s) in Company
27th May 20227:00 amRNSRecord Emerald Auction Results
26th May 20227:00 amRNSIssue of Equity and Total Voting Rights update
24th May 20223:00 pmRNSDirector/PDMR Shareholding
10th May 20222:45 pmRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSPDMR shareholding and Total Voting Rights update
29th Apr 20222:30 pmRNSDividend Update
29th Apr 20227:00 amRNSNotice of AGM
28th Apr 202212:30 pmRNSIssue of Equity and Total Voting Rights update
26th Apr 202212:30 pmRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSDirector/PDMR Shareholding
19th Apr 20227:00 amRNSNo change statement, Notice of AGM and BBEE Report
14th Apr 202210:00 amRNSIssue of Equity and Total Voting Rights
8th Apr 202211:15 amRNSDividend Finalisation
7th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSRecord Emerald Auction Results
31st Mar 202212:30 pmRNSIssue of Equity and Total Voting Rights
25th Mar 20227:45 amRNSAudited Annual Results 2021 & Special Dividend
22nd Mar 20227:00 amRNSTrading Statement
24th Feb 202212:00 pmRNSIssue of Equity and Total Voting Rights
11th Feb 202212:30 pmRNSIssue of Equity and Total Voting Rights
3rd Feb 202212:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.